Departament de Ciència Animal i dels Aliments, Universitat Autònoma de Barcelona, 08193 - Bellaterra, Spain.
J Dairy Res. 2010 Feb;77(1):123-8. doi: 10.1017/S0022029909990562. Epub 2010 Jan 7.
The objective was to evaluate the effects of an inhibitor of alpha-amylase and glucosidase (acarbose, Pfizer Limited, Corby, UK) on ruminal fermentation, blood metabolism and microbial profile in dairy cows in a 2x2 cross-over experiment. Eight Holstein cows fitted with rumen cannulas (milk yield, 24.3+/-2.35 kg/d, body weight, 622+/-54 kg, days in milk, 183+/-67, 5 multiparous and 3 primiparous) were used. Treatments were: control (no additive, CTR) and alpha-amylase and glucosidase inhibitor (0.75 g acarbose-premix/cow per d, AMI). Animals were given ad-libitum access to a high non-fibre carbohydrate (NFC) partial mixed ration (PMR) containing 17.6% crude protein, 28.3% neutral detergent fibre, and 46.5% NFC in the dry matter and supplementary concentrate during milking. Blood samples were taken to determine blood glucose, insulin and urea within the first hour after the morning feeding on two separate days in each period. Samples of ruminal contents were collected during 3 d in each period at 0, 4 and 8 h after feeding to determine volatile fatty acid and ammonia-N concentrations and to quantify protozoa, Streptococcus bovis and Megasphaera elsdenii. Rumen pH was recorded electronically at 22-min intervals during 6 d in each period. Results were analysed using a mixed-effects model. Cows on AMI treatment spent less time with ruminal pH <5.6 compared with cows in the CTR group (3.74 and 6.52+/-0.704 h/d, respectively). Cows in the AMI group had greater daily average pH compared with those in the CTR group (6.05 and 5.92+/-0.042, respectively). AMI animals tended (P=0.09) to have lower Str. bovis to Meg. elsdenii ratio than CTR (4.09 and 26.8+/-12.0, respectively). These results indicate that dietary supplementation with acarbose in dairy cattle fed high-production rations may be effective in reducing the time for which rumen pH is suboptimal, with no negative effects on ruminal fermentation and blood metabolites.
目的在于评估 α-淀粉酶和葡萄糖苷酶抑制剂(阿卡波糖,辉瑞有限公司,英国科尔比)对奶牛瘤胃发酵、血液代谢和微生物区系的影响,该研究采用 2x2 交叉试验设计。试验选用 8 头安装有瘤胃瘘管的荷斯坦奶牛(产奶量 24.3+/-2.35kg/d,体重 622+/-54kg,产奶天数 183+/-67,5 头经产牛和 3 头初产牛)。试验处理为:对照组(无添加剂,CTRL)和 α-淀粉酶和葡萄糖苷酶抑制剂组(0.75g 阿卡波糖预混料/奶牛/天,AMI)。动物自由采食高非纤维碳水化合物(NFC)半混合日粮(PMR),该日粮干物质中含有 17.6%粗蛋白、28.3%中性洗涤纤维和 46.5%NFC,并在挤奶时补充精料。在每个试验期的两天内,于早晨饲喂后 1 小时内采集血液样本,以测定血糖、胰岛素和尿素。在每个试验期的 3 天内,于饲喂后 0、4 和 8 小时采集瘤胃液样本,以测定挥发性脂肪酸和氨态氮浓度,并定量分析原虫、牛链球菌和巨球形菌。在每个试验期的 6 天内,每隔 22 分钟记录瘤胃 pH 值。使用混合效应模型分析结果。与对照组(3.74 和 6.52+/-0.704h/d)相比,接受 AMI 处理的奶牛瘤胃 pH 值<5.6 的时间更少。与对照组相比,AMI 组奶牛的日平均 pH 值更高(6.05 和 5.92+/-0.042)。AMI 组动物的牛链球菌与巨球形菌的比值较对照组低(4.09 和 26.8+/-12.0),但差异不显著(P=0.09)。这些结果表明,在高生产日粮中添加阿卡波糖可有效减少奶牛瘤胃 pH 值不适的时间,且对瘤胃发酵和血液代谢物无负面影响。